Patents
Sitemap › A61 - Medical or veterinary science; Hygiene › A61P - Specific therapeutic activity of chemical compounds or medicinal preparations › A61P 37 - Drugs for immunological or allergic disorders
Patents for A61P 37 - Drugs for immunological or allergic disorders (117,141)
06/1998
06/11/1998WO1998024427A2 Compositions and methods for treating or preventing inflammatory diseases
06/11/1998WO1998016186A3 Monocyclic l-nucleosides, analogs and uses thereof
06/11/1998WO1998006749A3 Soluble monovalent and multivalent mhc class ii fusion proteins, and uses therefor
06/11/1998CA2607067A1 Compositions and methods for treating or preventing inflammatory diseases
06/11/1998CA2277580A1 Human chemokine beta-13
06/11/1998CA2274304A1 Novel calpaines, production and use thereof
06/11/1998CA2274249A1 Inhibitors of interleukin-1.beta. converting enzyme
06/11/1998CA2274145A1 Adaptor protein frs2 and related products and methods
06/11/1998CA2274095A1 Compositions and methods for administering pneumococcal dna
06/11/1998CA2274048A1 Pyrazoles as human non-pancreatic secretory phospholipase a2 inhibitors
06/11/1998CA2274019A1 Phenyl glyoxamides as spla2 inhibitors
06/11/1998CA2273881A1 Synthetic techniques and intermediates for polyhydroxy, dienyllactones and mimics thereof
06/11/1998CA2273845A1 Secreted proteins and polynucleotides encoding them
06/11/1998CA2273002A1 Immunotherapeutic imides/amides as pde iv and tnf inhibitors
06/11/1998CA2272148A1 Vitamin d3 derivatives
06/11/1998CA2224334A1 Self-enhancing, pharmacologically controllable expression systems
06/10/1998EP0846767A2 FtsL - A membrane bound protein from Streptococcus pneumoniae
06/10/1998EP0846700A1 Pollen Allergens
06/10/1998EP0846687A1 Pyrazoles as human non-pancreatic secretory phospholipase A2 inhibitors
06/10/1998EP0846466A2 Compositions for the treatment of rheumatoid-based arthritic diseases
06/10/1998EP0846178A1 Allergen-xcd32 fusion proteins
06/10/1998EP0846116A1 1-benzoyl-2-(indolyl-3-alkyl)-piperazine derivatives as neurokinin receptor antagonists
06/10/1998EP0846108A1 Amino-substituted thiadiazoles, pyrimidines, triazines or triazoles useful as ctf receptor antagonists
06/10/1998EP0845994A1 Combined use of interleukin-10 and cyclosporin for immunosuppression therapy
06/10/1998EP0845984A1 Use of aminoadamantane compounds as immunoregulators
06/10/1998EP0831817A4 Antigen-processing cell-targeted conjugates
06/10/1998EP0721346B1 Methods for inducing antigen-specific t cell tolerance
06/10/1998EP0693054B1 Cycloalkylhydroxyureas and their use as lipoxygenase inhibitors
06/10/1998EP0675719B1 Novel combination of benzoquinazoline antifolates and protecting agents
06/10/1998CN1184483A Fucopeptides
06/10/1998CN1038680C Dihydronaphtho £1, 2-b| pyrane derivative and its producing process and use
06/09/1998US5763621 Reaction of acid compound with hydroxylamine compound or amidation of acid
06/09/1998US5763614 1,4-dihydropyridine derivatives and methods of producing the same
06/09/1998US5763585 Modulators of t-cells for immunological disorders
06/09/1998US5763582 Derivatives of triterpenoid acids and uses thereof
06/09/1998US5763571 Amino acid sequences which inhibit binding
06/09/1998US5763567 Human amino acid sequences which can bind to and/or neutralize heparin
06/09/1998US5763484 Metabolites of linoleic acid and a-linolenic acid
06/09/1998US5763433 Pharmaceutical compositions containing 3-beta-hydroxylated 6,7-substituted steroid derivatives, and use thereof
06/09/1998US5763420 Method for modulating the immune system
06/09/1998US5763396 Method of treating or preventing type 1 diabetes by oral administration of insulin
06/09/1998US5763284 Methods for peptide synthesis and purification
06/09/1998US5763246 DNA encoding arginyl tRNA synthetase from staphylococcus aureus
06/09/1998US5763220 Human apoptosis-related calcium-binding protein
06/09/1998US5763210 Recombinant production of interferon-gamma binding proteins
06/09/1998US5763164 Immunogenic cancer proteins and peptides and methods of use
06/09/1998US5762943 And deacylated monophosphoryl lipid, carrier, and allergen
06/09/1998US5762939 Method for producing influenza hemagglutinin multivalent vaccines using baculovirus
06/09/1998US5762936 Antioxidant derived from lentil and its preparation and uses
06/09/1998US5762920 Megakaryocyte production
06/09/1998US5762905 Human neutralizing monoclonal antibodies to respiratory syncytial virus
06/09/1998CA2077907C Use of spiperone as an immunosuppressant and anti-inflammatory agent
06/04/1998WO1998023959A2 Diagnosis and treatment of insulin-dependent diabetes mellitus
06/04/1998WO1998023748A1 Methods for preventing graft rejection in transplantation and for producing a universal gene therapy host cell using lymphocyte activation (lag-3)
06/04/1998WO1998023741A1 Mutants of the lag-3 proteins, products for the expression of these mutants and use
06/04/1998WO1998023738A2 Novel prokaryotic polynucleotides, polypeptides and their uses
06/04/1998WO1998023644A1 Peptide derivatives
06/04/1998WO1998023636A1 Heptapeptide oxytocin analogues
06/04/1998WO1998023631A1 Novel bacterial polypeptides and polynucleotides
06/03/1998EP0845537A1 Recombinant retroviruses delivering vector constructs to target cells
06/03/1998EP0845530A2 Interferon gamma inducing factor
06/03/1998EP0845036A1 Functional role of adrenomedullin (am) and the gene-related product (pamp) in human pathology and physiology
06/03/1998EP0845035A2 Urocortin peptides
06/03/1998EP0845032A2 Isolated nucleic acid molecules, peptides which form complexes with mhc molecule hla-a2 and uses thereof
06/03/1998EP0844873A1 Carotenoid-nicotinamide-zinc compositions and methods of treatment using same
06/03/1998CN1183811A Method for isolation and purification of lipid cell-wall components
06/03/1998CN1183769A Alpha -(substd. alkylphenyl) -4 -(hydroxy -diphenylmethyl) -1 -piperidine butanol derivs., their preparation and their use as anti-histamines, anti-allergy agents and bronchodilators
06/03/1998CN1183722A Use of penciclovir for treatment of human herpes-virus-8
06/03/1998CN1038586C Process for preparing pyrazine derivs
06/03/1998CN1038585C Process for preparation of 2, 4 - and 2, 5 -substd. pyridine -N -oxides
06/02/1998US5760276 Aryl-and heteroarylcyclohexenyl substituted alkenes having retinoid agonist, antagonist or inverse agonist type biological activity
06/02/1998US5760248 Having improved metabolic stability
06/02/1998US5760180 Kits and dna(cdna) codes and cloning expression vectors
06/02/1998US5760084 Treating dermatological disorders
06/02/1998US5760073 Treatment of central nervous system disorders
06/02/1998US5760036 Enzyme inhibitors of retroviral protease for prevention of aids
06/02/1998US5760035 Piperidine compounds substituted with an aminoalkyl group and an aryloxyalkyl group, antiallergens, antiinflammatory agents, immunosuppressants
06/02/1998US5760018 Treatment of pain, inflammation, migraine, emesis
06/02/1998US5759993 Modified sialyl Lewisx compounds
06/02/1998US5759808 Immunoglobulins devoid of light chains
06/02/1998US5759775 Hybridization; amplification
06/02/1998US5759548 Using plant extract
06/02/1998US5759546 Treatment of CD4 T-cell mediated conditions
06/02/1998US5759543 Application of a cell culture of a fusarium fungus strain producer for medical uses
06/02/1998US5759536 Use of fas ligand to supress T-lymphocyte-mediated immune responses
06/02/1998US5759533 Neutrophil-activating peptide-2
06/02/1998CA2158632C Catechol diether compounds as inhibitors of tnf release
06/02/1998CA2006896C Benzene derivatives, their preparation and pharmaceutical compositions in which they are present
06/02/1998CA1339894C Fusion proteins with a eukaryotic ballast portion
05/1998
05/28/1998WO1998022605A1 Improved methods for transducing cells
05/28/1998WO1998022580A2 Bovine lactation associated immunotropic protein (cd14), encoding gene and application in b cell activation
05/28/1998WO1998022465A1 A1 adenosine receptor antagonists
05/28/1998WO1998022464A1 Xanthines and their therapeutic use
05/28/1998WO1998022460A1 Bicyclic aryl carboxamides and their therapeutic use
05/28/1998WO1998022457A1 Aryl and heteroaryl substituted fused pyrrole antiinflammatory agents
05/28/1998WO1998022418A1 Substituted phenols and thiophenols useful as antioxidant agents
05/28/1998WO1998022145A1 Immunization of infants
05/28/1998WO1998022130A1 Local use of il-1ra in corneal transplant rejection or disorders of the eye
05/28/1998WO1998022100A2 New use for 1,3-propanediol derivatives
05/28/1998WO1998016503A3 The preparation and use of ortho-sulfonamido aryl hydroxamic acids as matrix metalloproteinase and tace inhibitors
1 ... 1006 1007 1008 1009 1010 1011 1012 1013 1014 1015 1016 1017 1018 1019 1020 1021 1022 1023 1024 1025 1026 ... 1172